Pembelian
KMPH $50 Million Share Repurchase Program
When most of the companies are diluting their shares and insiders are selling, KemPharm, Inc. (KMPH) does the opposite.
Insiders are buying and the Board of Directors authorizes a program to repurchase up to $50 million of the Company’s outstanding stock valid through December 31, 2023. It is equivalent to 18% of KemPharm’s current market capitalization.
Because of the short term puts i have 2 approaches for KMPH:
dump to 7.17 and then go to 11.45
or
bounce from the strong support which it has right now and go to $14.50
Looking forward to read your opinion about it.
Insiders are buying and the Board of Directors authorizes a program to repurchase up to $50 million of the Company’s outstanding stock valid through December 31, 2023. It is equivalent to 18% of KemPharm’s current market capitalization.
Because of the short term puts i have 2 approaches for KMPH:
dump to 7.17 and then go to 11.45
or
bounce from the strong support which it has right now and go to $14.50
Looking forward to read your opinion about it.
DAILY HIGH-CONVICTION OPTIONS SIGNALS patreon.com/PremiumOptionsSignals
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
DAILY HIGH-CONVICTION OPTIONS SIGNALS patreon.com/PremiumOptionsSignals
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.